2.3.1.22	2-acylglycerol o-acyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=19419693&form=6&db=m	MGAT2 deficiency (CDG-IIa): The Life of J.	causal interaction,unassigned	3,0	
2.3.1.22	2-acylglycerol o-acyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21734185&form=6&db=m	Deficiency of MGAT2 increases energy expenditure without high-fat feeding and protects genetically obese mice from excessive weight gain.	causal interaction,ongoing research,therapeutic application,unassigned	3,4,3,0	
2.3.1.22	2-acylglycerol o-acyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22698140&form=6&db=m	MGAT2 deficiency ameliorates high-fat diet-induced obesity and insulin resistance by inhibiting intestinal fat absorption in mice.	causal interaction,unassigned	3,0	
2.3.1.22	2-acylglycerol o-acyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25315695&form=6&db=m	MGAT2 deficiency and vertical sleeve gastrectomy have independent metabolic effects in the mouse.	causal interaction,therapeutic application,unassigned	4,4,0	
2.3.1.22	2-acylglycerol o-acyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=25535286&form=6&db=m	Adult-onset deficiency of acyl CoA:monoacylglycerol acyltransferase 2 protects mice from diet-induced obesity and glucose intolerance.	causal interaction,ongoing research,therapeutic application,unassigned	4,4,1,0	
2.3.1.22	2-acylglycerol o-acyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=30831319&form=6&db=m	Defective Phosphatidylglycerol Remodeling Causes Hepatopathy, Linking Mitochondrial Dysfunction to Hepatosteatosis.	causal interaction,ongoing research,therapeutic application,unassigned	3,3,1,0	
2.3.1.22	Alzheimer Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=21368380&form=6&db=m	MGAT3 mRNA: A Biomarker for Prognosis and Therapy of Alzheimer's Disease by Vitamin D and Curcuminoids.	causal interaction,diagnostic usage,therapeutic application,unassigned	3,3,3,0	
2.3.1.22	Alzheimer Disease	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=22003913&form=6&db=m	Delineating Alzheimer's disease progression with MGAT3, a biomarker for improved prognosis and personalized therapy.	causal interaction,diagnostic usage,therapeutic application,unassigned	3,2,4,0	
2.3.1.22	Bardet-Biedl Syndrome	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=32789750&form=6&db=m	Novel variants in women with premature ovarian function decline identified via whole-exome sequencing.	diagnostic usage,unassigned	2,0	
2.3.1.22	beta-1,4-mannosyl-glycoprotein 4-beta-n-acetylglucosaminyltransferase deficiency	http://www.ncbi.nlm.nih.gov/htbin-post/Entrez/query?uid=26467158&form=6&db=m	Bisecting GlcNAc modification stabilizes BACE1 protein under oxidative stress conditions.	causal interaction,unassigned	4,0